Yi Xie

Chief Executive Officer chez EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED

61 ans

Finance

Health Technology

Consumer Services

Profil

Yi Xie is the founder of United Gene Group Ltd.
He is currently the Chairman & Chief Executive Officer at Extrawell Pharmaceutical Holdings Ltd., Vice Chairman & Chief Executive Officer at United Gene Holdings Ltd., Chairman at Changchun Extrawell Pharmaceutical Co., Ltd., and Professor at School of Life Sciences Fudan University.
He previously served as a Non-Executive Director at China Evoline Plc.

Postes actifs de Yi Xie

Sociétés	Poste	Début
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED	Chief Executive Officer	01/01/2012
United Gene Holdings Ltd.	Chief Executive Officer	15/02/2010
Changchun Extrawell Pharmaceutical Co., Ltd.	Chairman	15/02/2010
School of Life Sciences Fudan University	Corporate Officer/Principal	-

Tous les postes actifs de Yi Xie

Anciens postes connus de Yi Xie

Sociétés	Poste	Fin
China Evoline Plc China Evoline Plc Investment Banks/BrokersFinance China Evoline Plc currently does not have any operations. Previously, it was engaged in identifying a suitable acquisition, preferably in the natural resources or technology sectors. The company was founded on 2003 and is headquartered in London, the United Kingdom.	Director/Board Member	18/12/2008
United Gene Group Ltd.	Founder	-

Voir l'expérience en détail de Yi Xie

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yi Xie

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED	Health Technology

Entreprise privées	4
China Evoline Plc China Evoline Plc Investment Banks/BrokersFinance China Evoline Plc currently does not have any operations. Previously, it was engaged in identifying a suitable acquisition, preferably in the natural resources or technology sectors. The company was founded on 2003 and is headquartered in London, the United Kingdom.	Finance
United Gene Holdings Ltd.
United Gene Group Ltd.
Changchun Extrawell Pharmaceutical Co., Ltd.

Voir les connexions sociétés